Furthermore, he also informed that Unified Health Interface (UHI) will help in developing protocol-based system in healthcare.
The session was moderated by Mohd Yaman, Solution Consultant – Digital Media, Adobe.
The session was moderated by Roshun Povaiah, Editor, FinancialExpress.com.
The session was moderated by E Kumar Sharma, Deputy Editor, FinancialExpress.com.
According to Dr. Swaminathan, the potential of telemedicine can be explored and scaled up accordingly.
The session was moderated by Jaspreet Singh, Partner & National Leader, Grant Thorton Bharat LLP.
FE Digital Health Conclave: A-listers of healthcare sector discuss ways to develop digital solutions
The session was moderated by Sayantan Chatterjee, Executive Director, PwC.
The session was Moderated by Prof (Dr) Rajib Dasgupta, Chairperson, CSMCH, JNU and Managing Editor, Indian Journal of Public Health.
With more than 30 speakers and 150 delegates, Financial Express Digitalhealth Conclave 2023 aims to set the course for a healthier…
The company claimed that NURA centres will complete the procedure of complete body screening in 120 minutes followed by a…
The complex and rare Cancer cases will be discussed in Virtual Tumor Board (VTB), which has national and international oncology…
Reportedly, the programme is aimed at increasing access to innovative treatments in some of the world’s poorest countries.
It will also be a tool to support doctors in providing lactation consultation to the mothers delivering at their facility,…
According to the analyst consensus forecast on the GlobalData Pharma Intelligence Center, the drug is expected to reach $438 million…
With Co-Partner mfine and Silver Partner Adobe, the Second Edition of FE Digital Health Conclave will be held at the…
Leqembi is the second anti-Aβ mAb approved by the FDA for the treatment of Alzheimer’s Disease, following the FDA’s controversial…
According to a recent Lancet report, India is home to approximately 77 million people with diabetes, and these numbers are…
Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of USD 666 million in the U.S.…
